ReMynd, a Belgian biotech company, announced today that it has
received follow-on funding from pharma giant Roche for a potentially
disease-modifying Parkinson's drug whose development MJFF ...
Researchers at University College London Hospitals (U.K.) are starting a clinical trial to test Exenatide, a synthetic version of a compound originally found in Gila monster saliva. MJFF has funded ...